摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1609550-45-9

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1609550-45-9
化学式
C13H12FN3O2
mdl
——
分子量
261.256
InChiKey
WDFXQIWEURMHRI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.54
  • 重原子数:
    19.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    64.11
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    N-碘代丁二酰亚胺三乙胺三氟乙酸 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 sodium hydroxide 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 生成 N-[(2R)-2,3-dihydroxypropoxy]-5-(2-fluoro-4-iodoanilino)pyrimidine-4-carboxamide
    参考文献:
    名称:
    Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors
    摘要:
    The MAPK pathway is identified as one of the most important pathways involved in cell proliferation and differentiation. A key kinase in the pathway, the Mitogen-activated protein kinase kinase (MEK) is recognized as a promising target for antitumor drugs. Structure-based design and optimization of known MEK inhibitors resulted in identification of compound 10a as a potent non-ATP competitive MEK inhibitor in both in vitro and in vivo tests. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.03.086
  • 作为产物:
    描述:
    5-溴-4-嘧啶羧酸乙酯2-氟苯胺 在 palladium diacetate 、 caesium carbonate4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以70%的产率得到
    参考文献:
    名称:
    Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors
    摘要:
    The MAPK pathway is identified as one of the most important pathways involved in cell proliferation and differentiation. A key kinase in the pathway, the Mitogen-activated protein kinase kinase (MEK) is recognized as a promising target for antitumor drugs. Structure-based design and optimization of known MEK inhibitors resulted in identification of compound 10a as a potent non-ATP competitive MEK inhibitor in both in vitro and in vivo tests. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.03.086
点击查看最新优质反应信息